Pharmacodynamics and bactericidal activity of gatifloxacin in experimental pneumonia caused by penicillin-resistant Streptococcus pneumoniae

Chemotherapy

Volumn 50, Issue 3, 2004, Pages 107-112

  Yanagihara, Katsunori ^a   Fukuda, Yuichi ^a   Miyazaki, Yoshitsugu ^a   Tsukamoto, Kazuhiro ^a   Hirakata, Yoichi ^a   Tomono, Kazunori ^a   Kadota, Jun Ichi ^a   Tashiro, Takayoshi ^a   Murata, Ikuo ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Experimental pneumonia; Gatifloxacin; Penicillin resistant Streptococcus pneumoniae

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; INFLAMMATION; LUNG; MICROBIAL ACTIVITY; MORTALITY; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG EVALUATION, PRECLINICAL; FLUOROQUINOLONES; LUNG; MICE; MICE, INBRED CBA; OFLOXACIN; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; SURVIVAL RATE;

EID: 3242752693     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077883     Document Type: Article

References (15)

1. Appelbaum PC: Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992;15:77-83.
2. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, Chongthaleong A, Aswapokee N, Chiu CH, Lalitha MK, Thomas K, Perera J, Yee TT, Jamal F, Warsa UC, Vinh BX, Jacobs MR, Appelbaum PC, Pai CH: Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999;26:1206-1211.
3. Perry CM, Ormrod D, Hurst M, Onrust SV: Gatifloxacin: A review of its use in the management of bacterial infections. Drugs 2002;62:169-207.
4. Tomizawa H, Tateda K, Miyazaki S, Yamaguchi K: Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1998;4:103-106.
5. Andres D, Craig WA: Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob Agents Chemother 2002;46:1665-1670.
6. Tateda K, Takashima K, Miyazaki H, Matsumoto T, Hatori T, Yamaguchi K: Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob. Agents Chemother 1996;44:1520-1525.
7. Kusajima H, Kusakawa H, Ishida R, Okamura K: High-performance liquid chromatographic determination of gatifloxacin, a new quinolone, in biological fluids. Jpn J Chemother 1999;47(suppl 2):104-111.
8. Jones ME, Blosser-Middleton RS, Critchley IA, Thornsberry C, Sahm DF, Yamakita J, Akasaki M, Karlowsky JA: The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000. Chemotherapy 2002;48:232-237.
9. Joyanes P, Pascual A, Gimenez MJ, Garcia I, Aguilar L, Perea E: Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae. Chemotherapy 2001;47:409-414.
10. Ho PL, Que TL, Tsang DN, Ng TK, Chow KH, Seto WH: Emergence of fluoroquinolone resistance among multiple resistant stains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1999;43:1310-1313.
11. Chen DK, McGeer A, de Azavedo JC, Low DE, The Canadian Bacterial Surveillance Network: Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999;341:233-239.
12. Garcia-Rey C, Aguilar L, Baquero F: Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrob Agents Chemother 2000;44:3381-3382.
13. Coyle EA, Kaatz GW, Rybak MJ: Activity of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:1654-1659.
14. Davies TA, Kelly LM, Pankucii GA, Credito KL, Jacobs MR, Appelbaum PC: Antipneumococcal activity of gemofloxacine compared to those of nine other agents. Antimicrob. Agents Chemother 2000;44:304-331.
15. Saravolatz L, Manzor O, Check C, Pawlak J, Belian B: Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae. J Antimicrob Chemother 2001;47:875-877.